medigraphic.com
Órgano Oficial de la Asociación Mexicana de Infectología Pediátrica y la SLIPE.

2012, Number 100

<< Back Next >>

Rev Enfer Infec Pediatr 2012; 25.26 (100)

Extract from the Consensus document of the Spnish Society of Pediatric Infectious Diseases (SEIP) and the Vaccine Advisory Committee of the Spanish Association of Pediatrics (CAV-AEP) for vaccination in HIV-infected children

Mellado PMJ

Language: Spanish
References: 8
Page: 121-124
PDF size: 396.02 Kb.


Text Extraction

No abstract


REFERENCES

  1. Bekker V, Scherpbier H, Pajkrt D, Jurriaans S, Zaaijer H, Kuijpers TW. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics. 2006 Aug;118(2):e315-22.

  2. Ghosh S, Feyen O, Jebran AF, Huck K, Jetzek-Zader M, Bas M, Niehues T. Memory B cell function in HIV-infected childrendecreased memory B cells despite ART. Pediatr Res. 2009 Aug;66(2):185-90.

  3. Lange CG, Lederman MM, Medvik K, Asaad R, Wild M et al. Nadir CD4+ T-cell count and numbers of CD28+CD4+ T cells predict functional responses to immunizations in chronic HIV-1 infection. AIDS. 2003 Sep 26;17(14):2015-2023.

  4. Lao-araya M, Puthanakit T, Aurpibul L, Sirisanthana T and Sirisanthana V. Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy. Pediatrics 2007;120(5):e1190-e1202.

  5. Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, Havens P, Nesheim S, Read JS, Serchuck L, Van Dyke R; CDC; NIH; HIV Medicine Association of the IDSA; PIDS; AAP. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, NIH, the HIV Medicine Association of the IDSA, the PIDS, and the AAP. MMWR Recomm. Rep. 2009 Sep 4;58(RR-11):1-166.

  6. Rigaud M, Borkowsky W, Muresan P, Weinberg A, Larussa P, Fenton T, Read JS, Jean-Philippe P, Fergusson E, Zimmer B, Smith D, Kraimer J; Pediatrics AIDS Clinical Trials Group P1006 Team. Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy. J Infect Dis. 2008 Oct 15;198(8):1123-1130.

  7. Sutcliffe CG, Moss WJ. Do children infected with HIV receiving HAART need to be revaccinated? Lancet Infect Dis 2010;10:630-642.

  8. Tejiokem MC, Gouandjika I, Béniguel L, Zanga M-CE, Tene G, et al. HIV-infected children living in Central Africa have low persistence of antibodies to Vaccines used in the Expanded Program on Immunization. 2007;PLoS ONE 2 (12).e1260. doi:10.1371/journal.phone.0001260.




2020     |     www.medigraphic.com